longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

PASW

PASW
----

LongbridgeAI

Weekly Recap | Ping An Biomedical -6.2%, a messy, high-volatility week

Weekly Review
Sep 5, 2026 at 07:47 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Ping An Biomedical (PASW.US) had a rough week, falling 6.2% to close at $0.1226, underperforming the S&P 500 by about 6.29 percentage points. In fact, the stock opened on Monday (31 Aug) at $0.14, briefly spiked to $0.24, and then gave back most of that move over the following four sessions. Friday (4 Sep) saw a pullback from the open at $0.1220 to a low of $0.1151 before settling at $0.1226.

The Week

Ping An Biomedical (PASW.US) had a rough week, falling 6.2% to close at $0.1226, underperforming the S&P 500 by about 6.29 percentage points. In fact, the stock opened on Monday (31 Aug) at $0.14, briefly spiked to $0.24, and then gave back most of that move over the following four sessions. Friday (4 Sep) saw a pullback from the open at $0.1220 to a low of $0.1151 before settling at $0.1226. Volume remained concentrated in Monday’s blow-off, with roughly 362 million shares traded for the week, while the subsequent days saw a sharp drop-off in turnover.

Key Events

News flow this week revolved around 1 Sep (Tuesday). Pre-market screens showed Ping An Biomedical down 13.39%, while a midday update put the decline at 16.42%, with one headline citing ‘capital demanding more from the industry’ as a reason for valuation pressure. Two commentary pieces on the same day cast the stock as part of the ‘periphery’ or ‘island of misfit toys’ theme: one focused on AI and business transformation, the other on questionable players in a hot market. These are more sentiment and framing than company-specific announcements, as no earnings, regulatory or product updates hit the tape this week.

The Week Ahead

The upcoming macro calendar is front-loaded around 8–10 Sep. On 8 Sep (Tuesday), the NFIB Small Business Optimism Index arrives with a prior of 99.8. 10 Sep (Thursday) is the busiest, featuring initial jobless claims, the PPI and core PPI prints, existing home sales, wholesale sales, and the 10-year Treasury auction. A softer inflation or labour read could shift risk appetite, which matters for a low-priced, high-volatility stock like PASW.US.

In Short

This week’s message is a mix of high volatility and low conviction. The stock fell 6.2% but swung nearly 89% from peak to trough, so the decline understates the noise. The price-to-book ratio sits at around 2.4x, earnings are negative, and the latest daily turnover rate is just 0.73%, leaving the stock thinly traded. Intraday capital-flow data showed small and medium orders slightly tilted toward buying, but with zero large-order activity, the picture is fragmented. The real test next week is whether this thinly traded name can hold its lower range through a dense macro calendar.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Login to unlock1,878characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Ping An Biomedical

Ping An Biomedical

PASW.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--